Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Browse the detailed record of transactions filed by Shin Barry, Chief Financial Officer. Director active across 2 companies, notably TREVENA INC. In total, 18 reports have been published. Split: 0 buy · 1 sell. History available since 14 September 2021. The latest transaction was disclosed on 2 January 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Shin Barry
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
24,635 shares@ €1.642926.9% of flowCommon StockSEC:0001429560-21-000010:0
18 of 18 declarations
About Shin Barry
Shin Barry is Director Financier. The declarant has 18 filings in total, and, across the sampled recent filings from 2021-06-25 to 2026-01-05, the stated buy and sell amounts are EUR 0 and EUR 0, with tax withholding as the transaction nature. He is linked to TREVENA INC, where he is Acting COO and CFO, and to Compass Therapeutics, Inc., where he is CFO.